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THE COVER:
A mosaic rendition of the doctor-disciple Luke by internationallyknown artist Edmund Lewandowski graces the north exterior of the
Walter Schroeder Pavilion. Located on the southeast corner of the
hospital, the Schroeder Pavilion is the new home of expanded
outpatient and emergency care services at St. Luke’s Hospital.

1 982 AN N UAL REPORT: CANCER PROG RAM
St. Luke’s Hospital
Milwaukee, WI

.

We dedicate this report to Dorothy Black, who died of lung
cancer in early 1982. Serving as the hospital’s Public Relations
Director for many years, Dorothy was a good will ambassador for
the hospital. Fond memories remain in the hearts of many whose
lives she touched.
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COMMENTARY/CRITIQUE
The cancer committee continues to enhance activities for registry,
education and audit.
This annual report attests to the registry’s performance at an excellent
level.
Continuing medical education for the attending staff and the house
officers was complimented through participation in two activities. The
Security Savings and Loan Lectureship focused on immunology and its
relevance to clinical management and problems; multidisciplinary
interchanges of information and expression of judgement occurring
twice a month centered on clinical problems of patients currently
hospitalized.
Throughout the year the plan for enhancement of hospital services
was modified and moved forward. A thorough discussion of the options
for participation in a quality assessment program for the cancer
committee and the hospital was held.
The current report contains a long and short term audit concerning data
in regard to female breast carcinoma.
It has been the recommendation of the cancer committee that an active
evaluation be prepared for each long term audit and presented widely
throughout the hospital in order to share information and enlighten
participation in the quality assessment programs.
The long and short term data show that the patients over a five year
period remain at about 60% axillary node involvement at the time of
presentation. The common mode of therapy is a modified radical
mastectomy. This procedure has been endorsed by the National
Working Conference on Surgery and Breast Cancer. The determination
of estrogen receptors has risen approximately 1/3 over the course of
five years. The most recent data collection has enhanced retrieval of
size of the initial lesion, presentation of preoperative mammograms,
bone scans and liver chemistries as part of pretreatment staging.
We feel that our evolution from an already broad base of scientific
development, information and record retrieval will enhance optimal
care for quality and survival of life of patients.
Dr. J. P. Hanson
Cancer Committee Chairman
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Top TEN SITES
Total Cases Entered into the Registry
for the Ten-Year Period 1972 1981
-

941

LUNG

923

BREAST

865

COLON/RECTUM

478

PROSTATE

345

SKIN (excluding melanoma)

334

BLADDER

252

UTERUS

196

LYMPHOMA

177

LEUKEMIA

173

UNKNOWN PRIMARY

4,684 CASES

NO TE: As of mid- 7982, there are over 7,000 cases in the Registry.
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Top

TEN

SITES

Total Cases Entered into the Registry Each Year
(1972 1981)
-

—

—

1972

LUNG

7975

IWo

57 89

75

101 1O4 99 116 115 117

1973

1974

1977

1978

1979

1980

1987

BREAST

*

COLON/RECTUM

70

64 80

62

83 96

114 96 105 95

PROSTATE

28

33

32

38

55

51

44 60

SKIN tex.mdanoma)

33

36 24

37

32

24 48

BLADDER

22

18

30

29

42

42

UTERUS

21

22

792941

2626262121

LYMPHOMA

io s

18

14

21

1914243632

LEUKEMIA

ii

19

18

15

22

19

16

UNKNOWN
PRIMARY

14

1416

1416

18

18232614

*

48

39 24

35 47

44 25

22

Many cases diagnosed as “unknown primary”are later specified as
a particular site. The number of unknown primaries listed above are
those that still remain as “unknown” sites.
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66 71

16

79

HOSPITAL CANCER PROGRAM APPROVED
A surveyor from the American College of Surgeons visited St. Luke’s in
May of 1982 to talk with various physicians and other health
professionals involved in our Cancer Program. The results ofthis survey
arrived in September, granting our Cancer Program a three-year
approval, the maximum approval given by the College.
This approval indicates that all elements of our Cancer Program are
organized and functioning to provide educational, multidisciplinary
exchange on cancer patient management, to encourage quality control
and audits, and to monitor the success of primary and secondary
treatment through long-term follow-up.
Our hospital and medical staffwere commended forthe excellent effort
put forth to continually maintain and improve our Cancer Program.

REGISTRY OPERATIONS UPDATE
As of mid-1982, the Registry had over7,000 cases in itsfiles. 1982 marks
the tenth anniversary of computerization of the Registry.
Looking into the future, a new data system is on the horizon. St. Luke’s
plans to utilize the new data system created by the American College of
Surgeons for use in Cancer Registries nationwide. The system with its
Common Data Set is designed to aid in uniformity of data collection,
which would provide more uniform and meaningful regional and
national statistics.
Some additional items of information which will be collected in the new
system include size of tumor, regional nodes examined, regional nodes
positive, residual tumor, date of first recurrence, type of recurrence,
distant sites offirst recurrence, quality of survival, and more specifics as
to type of treatment. It will also include an updated histology section.
The latter months of 1982 were filled with planning and other activities
prior to implementation of the new system. Target date for operation of
the new data system is set for February, 1983.
Through change and improvement in the data system, it is our goal that
the Registry will be able to better serve the needs of St. Luke’s staff.
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MULTIPLE PRIMARIES
There are 423 patients in the Registry who have more than one primary
cancer. This is about 6% of the more than 7,000 cases registered. 231 of
the patients are female (100 living; 131 deceased) and 192 are male (68
living; 1 24 deceased). The majority ofthese patients havetwo primaries,
however, fourteen patients have three primaries and one patient has
four primaries.

SITES
The most common sites of occurrence for these primaries are
colon/rectum, lung, breast, prostate, bladder, and skin (excluding
melanoma).
Eighteen per cent of the patients have multiple cancers in the same site
(for example, right and left breast; two primaries in the colon/rectum),
and 59°h of the patients have cancers in different sites. (23°h are not
known in this respect as their other additional primaries were
diagnosed/treated elsewhere.)
Forty-one patients have two breast primaries; 25 patients have two
colon/rectum primaries.

PATIENTS HAVING MORE THAN TWO PRIMARIES
Fourteen of our 423 patients have three primaries, 10 males and 4
females. The most common sites among these patients are prostate
and skin.
One female patient in the Registry has four primaries—one breast
primary diagnosed in 1969 and three primaries diagnosed in 1978—
breast, colon, and skin. She expired in 1980 at the age of 89.
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MOST COMMON HISTOLOGIC TYPES
The most common histologic types found in these patients are:
253 (29%)Adenocarcinoma NOS (not otherwise specif led)!
Adenoma mallgnum!Cribrlfotm carcinoma
(1O
0k)
DuctaI!1nttHg duct!Tubular carcinoma
84
75 (9%)SquamOus cell carcinoma!
Epidermoid carcinoma NOS!
AcanthOma, malignant!Prickle cell carcinoma!
Cancroid!SPin0us cell carcinoma
50 (6°!o) Basal cell carcinoma NOS!ROdent ulcer!
Superficial multicentric basal cell carcinoma!
Basal cell epithelioma
43 (5°!o)CarcinOma NOS!Large cell carcinoma!
Epithelial neoplasm, malignant
(30
!o)TransitiOnal cell carcinoma NOS!
29
Basaloid jnoma!CloacOgenlc carcinoma!
Schneiderian carcinoma
23 (3°!o)PapillarY transitional cell carcinoma
24 (3O!o)AdenOcarcinOma poorly differentiated
29 (30!o)Adenocarcinoma!CarcinOma arising in
adenomatous polyp
252 (290!o)Miscellaneous other histologies

i total

histologic types

TIME DIFFERENCE BETWEEN DIAGNOSES OF
MULTIPLE PRIMARIES
The longest time period between diagnoses was a patient who had
melanoma diagnosed in 1948, a second primary in 1971—lung, and a
third primary_prostate—in 1972.
93 (270!o)DiagnOsed at the same time
30 (9°!o)Within six months
14 (4°!o)Six months—one year
1 26 (36°!o)One—five years
47 (13°!o)Over five years
38 (11°!o)Over ten years
34$*
*lnformation not known regarding some patients’ primarieswhich were
diagnosed!treated elsewhere.
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CARCINOMA: FEMALE BREAST
LONG-TERM PATIENT CARE
EVALUATION STUDY
This study of 50 patients was completed and submitted to the American
College of Surgeons in 1982 as part of a nationwide compilation of
statistics on breast cancer.

GENERAL INFORMATION
The patients stud ied were d iag nosed between Novem ber, 1 973, and
Decem ber, 1 976. Forty-n i ne patients were wh ite; one person ‘s race
was not recorded.
Age at diagnosis showed this range:
40-49: 6
50-59: 12
60-69: 19
70-79: 10
80-89: 2
90+ : 1
Twenty-five tumors were located in the left breast and 25 were located
in the right breast. Twenty-two were specified as OUQ (outer upper
quadrant), 4—OLQ (outer lower quadrant), 10—IUQ (inner upper
quadrant), O—ILQ inner lower quadrant), and 1—nipple area.

EXTENT OF DISEASE
Twenty-seven patients (54°k) had a stage of regional; 24 of these
patients had disease extending into the axillary nodes.
Fifteen patients had localized disease, 2 were in situ, 3 were distant
(1 with metastases to brain; 3 with metastases to bone), and 3 were
unknown/unspecified.
8

PATHOLOGICAL INFORMATION
The tissue source for pathological exam was the primary tumor site in
all 50 cases. The most frequent histologic type was ductal infiltrating—
36 of the cases having this histology.
Thirteen patients had an estrogen binding test done—7 were positive
and 6 were negative.
Forty patients had axillary nodes examined, and of these, 24 (60%)
showed axillary nodes containing cancer. Specifically, number of
nodes with cancer/number of nodes examined were as follows:
0/7, 0/8, 0/10, 0/11, 0/11, 0/11, 0/13, 0/13, 0/14, 0/15, 0/16, 0/16, 0/22,
0/23, 0/25, 0/30, 1/1, 1/7, 1/10, 1/10, 1/10, 1/11, 1/13, 1/13, 1/15, 1/15,
1/28, 2/2, 2/10, 2/11, 3/3, 3/16, 3/25, 4/4, 4/6, 4/16, 8/8, 14/15, 22/24,
38/54.

INITIAL DEFINITIVE TREATMENT
27
9
3
2
1
5
1
1
1

Surgery and Radiation (54°h)
Surgery only (18%)
Surgery, Radiation, Chemotherapy
Surgery, Chemotherapy
Surgery, Radiation, Chemotherapy, Hormones
Biopsy and Radiation
Biopsy and Chemotherapy
Biopsy, Radiation, and Hormones
Radiation only

The type of surgery most frequently performed was a modified radical
mastectomy with full axillary dissection—35 cases (70%). The oldest
patient in the study (90 years of age) had surgery and radiation for her
local disease.

END RESULT AT FIVE YEARS FROM DATE OF DIAGNOSIS
Twenty-five patients (50°k) were still alive five years after d ag nosis—21
were free of cancer, 4 had cancer present.
Twenty-one patients were dead. Fifteen had died because of cancer;
the other six were dead because of other causes (2 had cancer present;
4 had an unknown cancer status).
Four patients were lost to follow-up.
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CARCINOMA: FEMALE BREAST
SHORT-TERM PATIENT CARE
EVALUATION STUDY
This study of 25 patients was completed and submitted to the American
College of Surgeons in 1982 as part of a nationwide study of
breast cancer.
GENERAL INFORMATION
The patients stud ied were d iag nosed between Novem ber, 1 980, and
November, 1981. Nineteen patients were white, 1 was black, 1 was
Oriental, and 4 persons did not have their race recorded. Marital status
of the patients was documented as 3 never married, 9 married,
3 separated/divorced, and 10 widowed.
Age at diagnosis showed this range:
31-40: 1
41-50: 3
51-60: 3
61-70: 6
Over 70: 12
Ten patients had a tumor of the right breast; 15 had a tumor of the
left breast.

EXTENT OF THE DISEASE
2 In situ
3 Local
12 Regional
(3 with extension into adjacent tissue)
(9 with involvement of axillary nodes)
5 Distant metastases
(1 to lung; 1 to distant nodes; 1 to neck; 3 to bone)
3 Unknown
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HISTORY
For 21 of the 25 patients, the reason for admission was breast tumor.
Fifteen of these tumors were discovered by the patient; 10 were
discovered by a physician.
The time difference between date of discovery and date of diagnosis
was as follows:
10 within the same month
9 within one month
3 within two months
1 within three months
1 within 12 months
1 within 29 months
Five patients were recorded as pre-menopausal, 17 as postmenopausal. Six patients reported using hormones—3 for menopausal
symptoms. Eleven patients had no history of hormone usage. Age of
onset for menses ranged from 12-20 with 14 being the most frequent
age. Cessation of menses showed an age range of 36-56. Number of
pregnancies ranged from 0-10 with 2 being the most frequent.
Fifteen of the 25 patients indicated no family history of breast cancer.
Four patients had a mother with breast cancer and 3 had a sister with
breast cancer. Seven patients had a family member with cancer in
another site.

PRE-TREATMENT EXAMS (PRIOR TO AND AFTER ADMISSION)
ESSENTIAL-G EN ERAL
25
12
8
5
25
25
25
25
25

Complete physical
Rectal exam
Pelvic
Pap smear
Urinalysis
EKG
Chest x-ray
CBC
Blood chemistries

ESSENTIAL-SPECIFIC
21 Biopsy prior to treatment
9 Bone survey
3 Skull
3 Pelvis
3 Lumbar spine
21 Bone scan
19 Pre-op mammogram
19 Involved breast
15 Other breast

SPECIAL AS INDICATED
16 Liver scan
3 Sonogram
1 CAT scan
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INITIAL DEFINITIVE TREATMENT
11
6
3
2
2
1

Surgery only (44%)
Surgery and Chemotherapy
Sirgery and Radiation
Biopsy only
Biopsy, Radiation, Chemotherapy
Biopsy and Chemotherapy

PATHOLOGICAL INFORMATION
The tissue source was the primary tumor site in all 25 cases. The most
com mon h istolog ic type lou nd (1 4 cases—56%) was d uctal i nfiltra
ting; 7 tissue specimens showed lobular infiltrating. One case
showed Paget’s disease with underlying tumor, one papillary, one
medullary (with foci of intraductal), and one was adenocarcinoma
NOS (not otherwise specified).
Tumor size was documented in 19 cases and ranged from 2 cm. to
15 cm., the average size being 46 cm.
An estrogen binding test was done in 17 cases. Fourteen were
positive, 3 were negative.
Seventeen patients had axillary nodes examined, 11 showed axillary
nodes with cancer. Specifically, number of nodes with cancer/number
of nodes examined were as follows: 0/11, 0/8, O/”multiple”, 0/11,
0/13, 0/15, 1/9, 1/1, 1/21, 1/14, 2/7, 3/8, 3/24, 6/15, 6/10, 7/14, 9/9.
3rading ofthe tumor was as follows: 2weII differentiated, 4 moderately
differentiated, 9 poorly differentiated, and 10 unknown.
MORTALITY AND MORBIDITY
There were no deaths in the hospital among the 25 patients.
Complications were: 1 wound infection, 1 cardiac complication,
1 seroma.

LENGTH OF HOSPITALIZATION
17
5
1

l4daysorless
15-21 days
22-30 days

OTHER
None of the 25 patients had breast reconstruction.
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STATISTICS
ALL REGISTRY
BREAST CANCER PATIENTS

During the past ten years (1972-1981), 923 breast cancer primaries
have been entered in the Registry, 917 female and 6 male.

AGE AT DIAGNOSIS
Under2O:
21-30:
31-40:
41-50:
51-60:
61-70:
71-80:
81 :

0
5
46
185
214
246
152
75

(y%)

(5%)
(20%)
(23°h)
(27%)
(16°k)
(8%)

PATHOLOGICAL INFORMATION
The histologic types found in these cases are as follows:
57°h Ductal carcinoma
I 1 °h Adenocarcinoma, NOS (not otherwise specified)
7°k Carcinoma, NOS
7°h Lobular carcinoma
6% Comedocarcinoma, NOS
4°h Medullary carcinoma
3°h Intraductal carcinoma
5% Other misc. histologies

STAGE AT INITIAL DIAGNOSIS
3°h
42°k
39%
15%
l%

In situ
Local
Regional
Distant
Unknown
73

TREATMENT/STAGE

REG ISTRY BREAST CANCER PATI ENTS (1972-1981)

TOTALS

IN SITU

LOCAL

REGIONAL

DISTANT

SURGERY

266

23

193

40

10

0

RADIATION

187

0

54

105

25

3

CHEMOTHERAPY

45

0

12

15

18

0

SURGERY&
RADIATION

118

1

44

66

7

0

8

26

1

0

0

9

24

13

0

49

0

8

33

8

0

59

4

28

6

16

5

30

42

40

4

386

357

138
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SURGERY &
CHEMOTHERAPY
RADIATION &
CHEMOTHERAPY
SURGERY,
RADIATION,
CHEMOTHERAPY
DIAGNOSTIC
ONLY
(no treatment)
OTHER THERAPY
COMBINATIONS
TOTALS

*

117

923

30

Combinations of hormones, deprivation, surgery, radiation,
chemotherapy, or supportive therapy only.
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UNKNWN

FIVE-YEAR SURVIVAL: BREAST CANCER
444 Registry Cases Diagnosed 1972-1976
ALL STAGES

J00
90

88%

..

%%%

0 80
z

78%

5: 70
60

%%

U)
I-

z 50
40
30

20
JO
1

2
YEARS SURVIVING

Calculated by the direct method for computing observed survival
(no adjustments are made for deaths due to causes other than cancer)
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52%

